Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice.

Lee, Dajeong; Park, Young Hwan; Lee, Ji Eon; Kim, Hyuk Soon; Min, Keun Young; Jo, Min Geun; Kim, Hyung Sik; Choi, Wahn Soo; Kim, Young Mi

Lee, Dajeong; Park, Young Hwan; Lee, Ji Eon; Kim, Hyuk Soon; Min, Keun Young; Jo, Min Geun; Kim, Hyung Sik; Choi, Wahn Soo; Kim, Young Mi.

Afiliación

Lee D; Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
Park YH; Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
Lee JE; Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
Kim HS; College of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.
Min KY; Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
Jo MG; Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
Kim HS; Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
Choi WS; Division of Toxicology, College of Pharmacy, Sungkyunkwan University, Suwon 6419, Republic of Korea.
Kim YM; Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.

Biomol Ther (Seoul) ; 28(5): 456-464, 2020 Sep 01.

Article en En | MEDLINE | ID: mdl-32268657

Palabras clave

Dasatinib; Fyn; Lyn; Mast cell; Type I hypersensitivity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomol Ther (Seoul) Año: 2020 Tipo del documento: Article